Cite
Intracoronary abciximab in diabetic patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
MLA
Piccolo, Raffaele, et al. “Intracoronary Abciximab in Diabetic Patients with ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.” Vascular Pharmacology, vol. 73, Oct. 2015, pp. 32–37. EBSCOhost, https://doi.org/10.1016/j.vph.2015.06.001.
APA
Piccolo, R., Eitel, I., Galasso, G., Iversen, A. Z., Gu, Y. L., Dominguez-Rodriguez, A., de Smet, B. J. G. L., Mahmoud, K. D., Abreu-Gonzalez, P., Thiele, H., & Piscione, F. (2015). Intracoronary abciximab in diabetic patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Vascular Pharmacology, 73, 32–37. https://doi.org/10.1016/j.vph.2015.06.001
Chicago
Piccolo, Raffaele, Ingo Eitel, Gennaro Galasso, Allan Zeeberg Iversen, Youlan L. Gu, Alberto Dominguez-Rodriguez, Bart J.G.L. de Smet, et al. 2015. “Intracoronary Abciximab in Diabetic Patients with ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.” Vascular Pharmacology 73 (October): 32–37. doi:10.1016/j.vph.2015.06.001.